Intravenous (IV) Saline and Exercise in Postural Tachycardia Syndrome (POTS)

StatusActive, Not Recruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 2 years 11 months later Jun 2028 → Jun 2031
See other at-risk trials from Vanderbilt University Medical Center

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion pushed from Jun 2028 to Jun 2031
    • Eligibility criteria expanded, about 8 words
    • Secondary endpoints: details revised at 1 of 2 entries
    • Publications: details revised at 1 of 1 entry
  2. Re-verified, no change to tracked fieldsv21
  3. Primary and study completion dates: Jun 2026 to Jun 2028v20
  4. Primary and study completion dates: Jun 2024 to Jun 2026v19
  5. 2 versions Re-verified since Aug 22, 2022, no change to tracked fieldsv17-v18
Show 15 earlier versionsHide 15 earlier versions
  1. Lead sponsor: Vanderbilt University to Vanderbilt University Medical Center
    • Primary and study completion dates: Jun 2021 to Jun 2024
    v16
  2. Re-verified, no change to tracked fieldsv15
  3. Primary and study completion dates: Jun 2020 to Jun 2021v14
  4. Re-verified, no change to tracked fieldsv13
  5. Primary and study completion dates: Jun 2017 to Jun 2020v12
  6. Re-verified, no change to tracked fieldsv11
  7. Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    v10
  8. Primary and study completion dates: Jun 2014 to Jun 2017v9
  9. Re-verified, no change to tracked fieldsv8
  10. Primary and study completion dates: Jun 2013 to Jun 2014
    • Secondary endpoints: details revised at 1 of 2 entries
    v7
  11. 5 versions Re-verified since Jan 26, 2010, no change to tracked fieldsv2-v6
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The investigators will test whether an intravenous infusion of saline (salt water) will improve the exercise capacity in patients with postural tachycardia syndrome (POTS).
Trial Details
NCT Number NCT01000350
Lead Sponsor Vanderbilt University Medical Center
Conditions
(from sponsor)		 Postural Tachycardia Syndrome
Related terms Orthostatic Intolerance, Postural Orthostatic Tachycardia Syndrome, Tachycardia
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov